PDE4 Inhibitors For Asthma/COPD, Systemic

PDE4 inhibitors for asthma/COPD, systemic are used to treat many of the progressive lung disease associated with chronic obstructive pulmonary disease (COPD), such as emphysema, chronic bronchitis, and refractory asthma. They have an antiinflammatory effect on the lungs and are used to reduce the risk of COPD exacerbations. A commonly prescribed PDE4 inhibitor for asthma/COPD, systemic is Daliresp (roflumilast).

Drugs classified as PDE4 Inhibitors For Asthma/COPD, Systemic are frequently used to treat the following conditions:

• chronic obstructive pulmonary disease (COPD)

Click on a drug below in order to find information and discounted prices at pharmacies near you.